- Home
- RYTM vs CNX Comparison
RYTM vs CNX Comparison
Compare RYTM & CNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- CNX
- Stock Information
- Founded
- RYTM 2008
- CNX 1860
- Country
- RYTM United States
- CNX United States
- Employees
- RYTM N/A
- CNX N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- CNX Oil & Gas Production
- Sector
- RYTM Health Care
- CNX Energy
- Exchange
- RYTM Nasdaq
- CNX Nasdaq
- Market Cap
- RYTM 3.8B
- CNX 4.4B
- IPO Year
- RYTM 2017
- CNX 1999
- Fundamental
- Price
- RYTM $61.33
- CNX $32.28
- Analyst Decision
- RYTM Strong Buy
- CNX Hold
- Analyst Count
- RYTM 12
- CNX 13
- Target Price
- RYTM $76.75
- CNX $31.83
- AVG Volume (30 Days)
- RYTM 632.6K
- CNX 2.1M
- Earning Date
- RYTM 05-07-2025
- CNX 07-24-2025
- Dividend Yield
- RYTM N/A
- CNX N/A
- EPS Growth
- RYTM N/A
- CNX N/A
- EPS
- RYTM N/A
- CNX N/A
- Revenue
- RYTM $136,863,000.00
- CNX $1,579,627,000.00
- Revenue This Year
- RYTM $37.88
- CNX $30.92
- Revenue Next Year
- RYTM $72.84
- CNX $20.89
- P/E Ratio
- RYTM N/A
- CNX N/A
- Revenue Growth
- RYTM 48.88
- CNX 19.15
- 52 Week Low
- RYTM $35.35
- CNX $23.63
- 52 Week High
- RYTM $68.58
- CNX $41.93
- Technical
- Relative Strength Index (RSI)
- RYTM 51.78
- CNX 56.44
- Support Level
- RYTM $58.72
- CNX $31.20
- Resistance Level
- RYTM $63.24
- CNX $32.52
- Average True Range (ATR)
- RYTM 2.43
- CNX 0.96
- MACD
- RYTM -0.15
- CNX -0.07
- Stochastic Oscillator
- RYTM 65.51
- CNX 54.05
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About CNX CNX Resources Corporation
CNX Resources Corp is an independent low carbon intensity natural gas and midstream company engaged in the exploration, development, production and acquisition of natural gas properties in the Appalachian Basin. The company's operating segment include Shale and Coalbed Methane. It generates maximum revenue from the Shale segment. It also has other segment that includes nominal shallow oil and gas production.